Barinthus Biotherapeutics plc. 10-Q filing
Filed 2026-04-30 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001828185-26-000019
- Form type
- 10-Q
- CIK
- 0001828185
- Primary document
- https://www.sec.gov/Archives/edgar/data/1828185/000182818526000019/brns-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Barinthus Biotherapeutics plc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-6.1M | - | - |
| Net Income | $-5.5M | - | - |
| Eps Basic | -0.14 | - | - |
| Eps Diluted | -0.14 | - | - |
| Cash And Equivalents | $65.9M | - | - |
| Total Assets | $92.1M | - | - |
| Total Liabilities | $25.7M | - | - |
| Shareholders Equity | $66.4M | - | - |
| Operating Cash Flow | $-3.4M | - | - |
| Capital Expenditures | $0 | - | - |